WithdrawnNot Applicable

Electrocautery vs Q-switch for Seborrheic Keratosis

0Started 2015-08

Plain-language summary

The primary objective of this study is to compare the efficacy and risk of adverse events of electrocautery versus 532 nm Q-switched neodymium-doped yttrium aluminium garnet (Nd:YAG) laser for the treatment of flat seborrheic keratoses. This study is a pilot study designed to determine feasibility of these procedures.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Subjects are Caucasian or Asian.
✓. Subjects who are between 18-65 year olds.
✓. Subjects have flat or macular seborrheic keratosis on dorsum of the hands and wrists, extensor surfaces of the forearms. The diagnosis of flat seborrheic keratosis is confirmed by two clinical dermatologists using routine clinical examination and dermoscopy.
✓. Subjects have Fitzpatrick skin type I-III.
✓. Subjects are in good health.
✓. Subjects have the willingness and the ability to understand and provide informed consent and communicate with the investigator.

Exclusion criteria

✕. History of keloids or hypertrophic scars.
✕. Pregnant or lactating or intends to become pregnant in the next 3 months.
✕. Active skin disease or skin infection in the treatment area.
✕. Previous history of lidocaine allergy.
✕. History of methemoglobinemia
✕. Unable to understand the protocol or to give informed consent.
✕. Any other condition that would, in the professional opinion of the investigator, potentially affect response or participation in the clinical study or would pose as an unacceptable risk to subject.

What they're measuring

Change in Pigmentation from baseline to week 18

Timeframe: Baseline and 18 weeks

Change in lesion texture from baseline to week 18

Timeframe: Baseline and 18 weeks

Trial details

NCT IDNCT02366559

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-12

View on ClinicalTrials.gov More Keratosis, Seborrheic trials